Literature DB >> 885857

Isolation and amino acid sequence of COOH-terminal fragments from the beta subunit of human choriogonadotropin.

S Birken, R E Canfield.   

Abstract

The amino acid sequence of the unique COOH-terminal region of the beta subunit of human choriogonadotropin has been reinvestigated. The desialylated subunit was digested with thermolysin and a 27-residue peptide from positions 115 through 141 isolated in a high yield. Quantitative Edman sequence degradation of this peptide, of another peptide produced by thermolysin digestion containing residues 142 to 145, and of two tryptic peptides (residues 123 to 145, 134 to 145) has established that the amino acid sequence of this region is: (formula: see text). In addition, the positions of attachment of the carbohydrate moieties to serine residues was established by a direct procedure using alkaline elimination and 35S-labeled sulfite addition, which yields [35S]-cysteic acid residues at the site of a substituted serine. Carbohydrate side chains in the COOH-terminal region have been shown to exist at residues 121, 127, 132, and 138. These studies have also resulted in the development of improved methods for the purification of COOH-terminal peptides of the human choriogonadotropin beta subunit.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 885857

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Expression of type II chorionic gonadotropin genes supports a role in the male reproductive system.

Authors:  Andrew M Parrott; Ganapathy Sriram; Yijun Liu; Michael B Mathews
Journal:  Mol Cell Biol       Date:  2010-11-15       Impact factor: 4.272

2.  Secretory trafficking signal encoded in the carboxyl-terminal region of the CGbeta-subunit.

Authors:  Albina Jablonka-Shariff; Irving Boime
Journal:  Mol Endocrinol       Date:  2009-01-08

Review 3.  Glycoprotein hormone isomorphism and assay discrepancy: the paradigm of luteinizing hormone (LH).

Authors:  S Costagliola; P Niccoli; P Carayon
Journal:  J Endocrinol Invest       Date:  1994-04       Impact factor: 4.256

4.  Efficient extraction and sensitive radioimmunoassay for hCG in human urine.

Authors:  T Shimizu; S Matsuura; M Mochizuki
Journal:  Arch Gynecol       Date:  1984

Review 5.  Controversies in plastic surgery: suction-assisted lipectomy (SAL) and the hCG (human chorionic gonadotropin) protocol for obesity treatment.

Authors:  T Vogt; D Belluscio
Journal:  Aesthetic Plast Surg       Date:  1987       Impact factor: 2.326

6.  Effects of preventing O-glycosylation on the secretion of human chorionic gonadotropin in Chinese hamster ovary cells.

Authors:  M M Matzuk; M Krieger; C L Corless; I Boime
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

7.  Molecular cloning of pituitary glycoprotein alpha-subunit and follicle stimulating hormone and chorionic gonadotropin beta-subunits from New World squirrel monkey and owl monkey.

Authors:  Jonathan G Scammell; Jane D Funkhouser; Felricia S Moyer; Susan V Gibson; Donna L Willis
Journal:  Gen Comp Endocrinol       Date:  2007-08-24       Impact factor: 2.822

8.  Design of a long-acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin beta subunit to the follitropin beta subunit.

Authors:  F A Fares; N Suganuma; K Nishimori; P S LaPolt; A J Hsueh; I Boime
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

9.  A human myeloma immunoglobulin G binding four moles of calcium associated with asymptomatic hypercalcemia.

Authors:  G Merlini; L A Fitzpatrick; E S Siris; J P Bilezikian; S Birken; S Beychok; E F Osserman
Journal:  J Clin Immunol       Date:  1984-05       Impact factor: 8.317

10.  Characterization of a carboxyterminal peptide fragment of the human choriogonadotropin beta-subunit excreted in the urine of a woman with choriocarcinoma.

Authors:  S Amr; R E Wehmann; S Birken; R E Canfield; B C Nisula
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.